Clinical Trial Update: Effect of LAPS-Exendin on Body Weight in Obese Population [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing LAPS-Exendin for body weight reduction in obesity has completed. The document does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LAPS-Exendin

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Obesity | Phase 2 | Status: COMPLETED